Early insights hint at the intriguing relationship between the content of dreams and self-harm.

In theory, mirtazapine may worsen OCD, or it may help. This first-of-its-kind trial puts it to the randomized test.

A large analysis raises questions about antidepressant efficacy in certain age groups, and also finds a sweet spot.

Lithium’s reputation as a difficult med may have more to do with branding than reality, according to this large analysis of mood stabilizer adherence.

This study made headlines with its surprising results, but you’ll want to read the fine print to understand how it informs practice.

Deep Brain Stimulation is a surgically invasive procedure that is used in an attempt to treat several conditions including obsessive compulsive disorder in some youths. But does it work? Read our research update so you can better guide families on this high-risk decision.

Pregnant patients with OUD may be reluctant to reveal their substance use for fear of losing their baby if reported to Child Protective Services. But this recent study shows that pregnant patients receiving medication treatment for OUD were more likely to leave the hospital with their baby than patients not receiving treatment.

Recent preliminary research reveals that psilocybin helped participants with alcohol use disorder cut back on drinking. Dive in to discover how this psychedelic compound might offer hope for patients who have found other current treatments ineffective.

By initiating LAIs early in the course of a patient’s illness, we can significantly delay the time to first hospitalization in young adults. 

This large study gives us reassuring data about neurodevelopmental outcomes in children exposed to several second-generation antipsychotic medications during pregnancy.